Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Tereza Filipi, Zuzana Heřmanová, Jana Turečková, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 261-261
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

The blood-brain barrier in aging and neurodegeneration
Emily G. Knox, María R. Aburto, Gerard Clarke, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2659-2673
Open Access | Times Cited: 386
Reactive gliosis in traumatic brain injury: a comprehensive review
Zuzana Amlerova, Martina Chmelová, Miroslava Andĕrová, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 19
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Abid Bhat, Bipul Ray, Arehally M. Mahalakshmi, et al.
Pharmacological Research (2020) Vol. 160, pp. 105078-105078
Closed Access | Times Cited: 82
Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation
Elisa Giacomelli, Björn F. Vahsen, Elizabeth L. Calder, et al.
Cell stem cell (2022) Vol. 29, Iss. 1, pp. 11-35
Open Access | Times Cited: 66
Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
Tiziana Bonifacino, Roberta Arianna Zerbo, Matilde Balbi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12236-12236
Open Access | Times Cited: 64
Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
Stefano Raffaele, Marta Boccazzi, Marta Fumagalli
Cells (2021) Vol. 10, Iss. 3, pp. 565-565
Open Access | Times Cited: 63
Gene Therapy in Amyotrophic Lateral Sclerosis
Ton Fang, Goun Je, Peter Pacut, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2066-2066
Open Access | Times Cited: 47
Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in rats
Rajeshwar Kumar Yadav, Sidharth Mehan, Rakesh Sahu, et al.
Human & Experimental Toxicology (2022) Vol. 41
Open Access | Times Cited: 39
The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review
Elżbieta Cecerska‐Heryć, Maja Pękała, Natalia Serwin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2643-2673
Open Access | Times Cited: 36
More Than Mortar: Glia as Architects of Nervous System Development and Disease
Inês Lago‐Baldaia, Vilaiwan M. Fernandes, Sarah D. Ackerman
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 56
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives
Gayathri R. Ediriweera, Liyu Chen, Justin J. Yerbury, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 6, pp. 2142-2160
Closed Access | Times Cited: 46
Destination Amyotrophic Lateral Sclerosis
Matt Keon, Benjamin Musrie, Marcel E. Dinger, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 42
Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
Andrijana Lazic, Vanda Balint, Danijela Stanisavljević Ninković, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4995-4995
Open Access | Times Cited: 32
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies
Jameel M. Al-Khayri, Mithunan Ravindran, Akshatha Banadka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1391-1391
Open Access | Times Cited: 7
Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology
Irit Reichenstein, Chen Eitan, Sandra Díaz-García, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 523
Open Access | Times Cited: 51
Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis
Gabriel Rodrigues Coutinho Pereira, Bárbara Abrahim-Vieira, Joelma Freire De Mesquita
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247841-e0247841
Open Access | Times Cited: 37
Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons
Marta Barbosa, Cátia Gomes, Catarina Sequeira, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 37
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
Fabiola De Marchi, Ivana Munitić, Amedeo Amedei, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 958-978
Open Access | Times Cited: 37
Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats
Rakesh Sahu, Sidharth Mehan, Sumit Kumar, et al.
Toxicology Reports (2022) Vol. 9, pp. 977-998
Open Access | Times Cited: 26
Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways
Kajal Sherawat, Sidharth Mehan
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 8, pp. 1647-1667
Closed Access | Times Cited: 15
Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
Ileana Lorenzini, Eric Alsop, Jennifer Lévy, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Overview of current and emerging therapies for amytrophic lateral sclerosis
Jeff Prescott, Angelia Szwed, Danielle Jamison, et al.
The American Journal of Managed Care (2020) Vol. 26, Iss. Suppl 9, pp. S191-S197
Open Access | Times Cited: 34
S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System
Nadia D’Ambrosi, M Milani, Savina Apolloni
Cells (2021) Vol. 10, Iss. 4, pp. 798-798
Open Access | Times Cited: 31
Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone
Diana Díaz‐García, Águeda Ferrer-Donato, José M. Méndez‐Arriaga, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 11, pp. 4838-4849
Open Access | Times Cited: 23
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma
Levi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top